“Integration of AI and Cloud-Based RTSM Solutions”
- One prominent trend in the global RTSM market is the increasing integration of artificial intelligence (AI) and cloud-based technologies into RTSM platforms
- These Innovations enhance the efficiency, scalability, and real-time adaptability of clinical trial operations by enabling predictive analytics, automated decision-making, and remote access across geographically dispersed sites
- For instance, AI-driven algorithms can optimize drug supply forecasting and patient randomization, reducing waste and improving enrollment balance, while cloud-based systems support decentralized trials by offering centralized access to data and system functionalities
- Cloud integration also improves collaboration among sponsors, CROs, and clinical sites, streamlining regulatory compliance and data management
- This trend is transforming the clinical trial landscape, driving demand for intelligent, agile RTSM solutions that can support increasingly complex trial designs and global operations
